NES
BBH icon

New England Securities’s VanEck Biotech ETF BBH Stock Holding History

New England Securities’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$986K Buy
8,543
+7,744
+969% +$873K 0.35% 63
2014
Q3 		$85K Sell
799
-7,611
-90% -$770K 0.03% 465
2014
Q2 		$802K Buy
8,410
+7,054
+520% +$632K 0.28% 87
2014
Q1 		$123K Sell
1,356
-9,369
-87% -$911K 0.05% 352
2013
Q4 		$949K Buy
10,725
+10,410
+3,305% +$871K 0.39% 56
2013
Q3 		$26K Buy
315
+60
+24% +$4.71K 0.01% 683
2013
Q2 		$17K Buy
+255
New +$17.7K 0.01% 721

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
LFM
Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return

New England Securities's BBH Position: Q4 2014 in Review

New England Securities increased its VanEck Biotech ETF (BBH) stake by 969% in Q4 2014, buying an estimated $873K and bringing the position to 8,543 shares worth $986K. The position accounts for 0.35% of the portfolio, ranked #63.

New England Securities first reported a position in BBH in Q2 2013 and has held it in 7 quarters since. 68 funds tracked by Wall St. Rank hold BBH as of Q4 2014.

  • New England Securities held 8,543 shares of VanEck Biotech ETF worth $986K as of Q4 2014.
  • New England Securities bought 7,744 VanEck Biotech ETF shares in Q4 2014, an estimated $873K.
  • VanEck Biotech ETF made up 0.35% of New England Securities's portfolio in Q4 2014, its #63 holding.
  • New England Securities first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 7 quarters since.
  • 68 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.